Property | Value |
?:abstract
|
-
Increasing severity of ketoacidosis in newly diagnosed type 1 diabetes (T1D) has been reported during the coronavirus 2019 disease (COVID-19) pandemic in Germany[1] and cases of delayed presentation of children with T1D have also been reported in Italy[2] and the United States[3]. There are significant differences in healthcare delivery systems and socioeconomic status (SES) between the United States and Europe, prompting us to evaluate if delayed presentation can be documented in a large pediatric diabetes center in the United States.
|
?:creator
|
|
?:doi
|
|
?:doi
|
|
?:journal
|
|
?:license
|
|
?:pdf_json_files
|
-
document_parses/pdf_json/4f3e58d1cadfa55afd7c6b31c837556de0fd279d.json
|
?:pmc_json_files
|
-
document_parses/pmc_json/PMC7744830.xml.json
|
?:pmcid
|
|
?:pmid
|
|
?:pmid
|
|
?:publication_isRelatedTo_Disease
|
|
is
?:relation_isRelatedTo_publication
of
|
|
?:sha_id
|
|
?:source
|
|
?:title
|
-
A trend towards an early increase in ketoacidosis at presentation of paediatric type 1 diabetes during the coronavirusā2019 pandemic
|
?:type
|
|
?:year
|
|